At a glance
ClinicalIndex Comparison RecordN/ACompleted· 26 enrolled
Drug / intervention
JJVC Marketed Contact Lensdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of 2-Week Reusable ACUVUE 2 Vivid Style
In Brief
A clinical study evaluating JJVC Marketed Contact Lens for Visual Acuity. Completed, enrolled 26 participants across 1 site.
Detailed Summary
This will be a single site, non-randomized, dispensing, brand-masked to the subject, bilateral single treatment study. There will be 2 study visits with a 10 to 14-day contact lens wear period between visits.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartJan 2018
First PostedFeb 2018
Primary CompletionFeb 2018
TodayJul 2026
First PostedFeb 13, 2018
Enrollment StartJan 16, 2018
Primary CompletionFeb 14, 2018
TodayJul 2, 2026
Enrollment to primary: 28 daysPosted 8.4 years ago
Interventions
JJVC Marketed Contact Lensdevice
Female subjects that are habitual contact lens wearers between the ages of 18 to 39 will be dispensed 1 treatment of the JJVC Marketed Contact Lens during the 2-visit study.